Cambridge, UK, 30 July 2018
TTP plc (TTP), a leading independent technology and product development company, and Cubed Laboratories (Cubed), a developer of rapid, DNA-based molecular diagnostic devices and test kits, today announced the successful completion of a project to develop Cubed’s core product, the NESDEP portable laboratory for pathogen detection. This accurate, high-throughput, and easy-to-use system has benefits in the food safety industry and potentially beyond.
Cubed engaged TTP towards the end of 2017 to undertake a rapid redesign and repackaging of its NESDEP device. Working from the base technology developed by Cubed, TTP’s Desktop Biology team conducted a bottom-up repackaging and development programme focussing on aesthetics, ease-of-use, and manuf...
Cambridge, UK, 02 July 2018
TTP, based at Melbourn Science Park, have pledged £50,000 a year for the next two years to further help develop the school’s high-quality science teaching, both within the curriculum and outside it.
The partnership, brokered by Melbourn governor Brian Clarkstone, comes as the college marks the dawn of a new era in their science department with a new head, Simon Callow, starting this term and leading a team in which the majority joined the school during 2017.
Simon Holmes, Principal, said “This is a fantastic opportunity to boost the Science experience of our students, both inside and outside lessons. Once we knew the money was confirmed our challenge was to recruit the highest calibre of Science teachers to join our existing staff and move things forwards. With Mr Callow and Dr Wilson, who arrived in January, I am confident we have the lead...
TTP plc (TTP), a leading independent technology and product development company, and Camena Bioscience, a developer of pioneering technology that profiles small molecules, such as metabolites, nutrients or medicines in liquid samples, announced today that they are collaborating to develop an instrument to monitor the health of cell cultures. The new instrument will be used in biologic medicine manufacturing, and will be developed by TTP as part of a new project led by Camena Bioscience and co-funded by Innovate UK, the UK’s innovation agency, with GSK plc and The Centre for Process Innovation as further project partners.
TTP will integrate Camena Bioscience’s proprietary small-molecule detection technology into a new instrument that will allow researchers to monitor metabolite levels in cell cultures more easily. The resulting better understanding of the condition of the cell culture, which is crucial for consistent synthesis of high-quality biologic products, promises to substant...
Cambridge, UK, 09 May 2018
TTP challenged the students to produce a short video analysing the ergonomics and usability of objects from everyday life. Successful applicants attended a STEM outreach day at their site in Melbourn, where they experienced what it is like to be a technology consultant and how the development of products and technology can change lives.
The students worked collaboratively to brainstorm, create and refine prototypes for an innovative syringe design to be used in fat-grafting reconstructive surgery. Their ideas ranged from operating the syringe via a foot pump to minimise pressure on the wrist, to controlling flow rate using a gear in a similar way to a pipette filler, and a high-tech syringe with controls inspired by the variable temperature/speed settings on hairdryers.
TTP consultants from across the organisation took part in the activity day to talk to students about the surgical procedure and provided them with guidance throughout the day. The six students that most impressed t...
Year 12 students from Hills Road Sixth Form College, Long Road Sixth Form College and Comberton Sixth Form were invited to apply for an activity day with TTP Group, a Founding P...
TTP Plc (TTP), a leading independent technology and product development company, and Sphere Fluidics, which provides single cell analysis systems underpinned by its patented picodroplet technology, today announced the launch of the Cyto-Mine® Single Cell Analysis System. The Cyto-Mine system automates single cell analysis, sorting, imaging and dispensing to help boost throughput and sensitivity throughout the biopharmaceutical discovery process.
Sphere Fluidics approached TTP to address the challenges associated with the development of a highly complex laboratory instrument and microfluidic cartridge. In less than three years, the partnership has delivered the Cyto-Mine instrument, based on proprietary algorithm software and optical hardware from Sphere Fluidics, which enables single cell compartmentalisation and fluorescence-assisted sorting. The instrument is compatible with the Cyto-Cartridge®, a disposable microfluidic biochip that integrates Sphere Fluidics’ core technology i...
A novel and disruptive analysis and monoclonal assurance system for drug discovery and development
Cohort company SEA, together with TTP plc, has been selected to develop technology designed to improve the efficiency and timely delivery of supplies to frontline battlefield assets.
The technology forms part of the UK MoD’s Defence and Security Accelerator Autonomous Last Mile Re-Supply programme and seeks to provide military logistics specialists with a better understanding of future supply and demand at the frontline, identifying which supplies will be required, where and when.
Such information is crucial in helping to deliver vital supplies quickly and efficiently to maintain operational tempo and enable successful mission outcomes.
The solution proposed by SEA and TTP is based on provision of near real-time usage information of Combat Supplies (CSUPS) through exploitation of the opportunities provided by platforms with an integrated, open architecture and use of a neural net based Demand Forecast expert system to provide a forecast of supply and demand based on the received ...
TTP has been developing cutting edge technologies for the Life Science industry for nearly 3 decades. Our scientists and engineers inhabit the fascinating and endlessly changing intersection between physics, engineering and the biological sciences, spotting opportunities to create new technologies and tools for the advancement of this exciting field.
Our focus areas include: bioprocess (manufacture based on living cells or cell products), human and animal diagnostics, biosensors, and instrumentation for molecular biology and pharmaceutical applications.
In addition to our Life Science expertise we also create disruptive products based on advances in technology and engineering innovation. TTP’s technology lies behind many products and processes in areas as diverse as communications, digital printing, instrumentation, consumer and industrial products, medical devices, cleantech and security systems.
Visit ttpblog.com to find out more.
With the Bridgestone World Solar Challenge (BWSC) drawing closer, Cambridge University Eco Racing (CUER) has embarked on the first stage leading up to one of the greatest automotive challenges in the world. Their entry Mirage – which will shortly arrive in Australia – will have to endure a gruelling 3,000 km marathon from Darwin to Adelaide on 8th – 15th October 2017, facing some of the harshest conditions imaginable.
Mirage will be the seventh car designed and built by the CUER team, a group of 60 ambitious students from the University of Cambridge. Now celebrating their 10th anniversary, the team’s knowledge of automotive engineering and aerodynamics has enabled them to utilise cutting-edge technology to push the boundaries of what is possible for solar-powered cars.
Tony Purnell, Head of Technical Development at British Cycling and a member of CUER’s Steering Committee, comments that his endevours to achieve greater efficiency at British Cycling are not disimilar to that of the...
With the Bridgestone World Solar Challenge (BWSC) drawing closer, Cambridge University Eco Racing (CUER) has embarked on the first stage leading up to one of the greatest automo...
TTP plc, a leading technology and product development company, and New England Biolabs, Inc. (NEB®), an industry leader in the discovery and production of enzymes for molecular biology applications, today announce that they have established a non-exclusive partnership to offer services to molecular diagnostic technology developers. The new offering will include comprehensive product development services that span instrumentation, consumables and reagents.
The partnership is focused on supporting customers in the molecular diagnostic and wider life science space to rapidly transition ideas into commercially successful products. The services will couple NEB’s catalog of reagents and expertise in enzyme development and manufacturing with TTP’s Desktop Biology™ product development and physical engineering know-how, to provide capabilities that allow the delivery of more complete solutions, spanning from consumables and instrumentation through to reagents.
Dr. Giles Sanders, Consultant...
New offering will include integrated and comprehensive product development services for fast tracking innovation, progressing ideas into commercial products
TTP Plc (TTP), a leading independent technology and product development company, is seeking development and go-to-market partners for FormaJetTM, a novel printhead platform designed for true multi-colour bioprinting.
When commercialised, FormaJetTM will enable digital processing and bioprinting of molecules for deposition and dispensing. The technology can be tailored to suit TTP’s development partners’ specific market needs, with an initial demo configuration allowing easy loading of 96 colours from SBS plates. The platform is capable of addressing a broad range of reagent types from proteins, peptides and DNA, to low viscosity polymers, organic chemicals, volatile solvents and solid-loaded materials.
FormaJetTM has been conceived by a team which combines TTP’s expertise in diagnostics, drug discovery, and droplet-based digital printing. It will use droplet generation and control technology which has been proven in applications ranging from drug delivery to inkjet printing, and f...
Novel droplet dispensing concept will enable high-speed, high-density, many-colour printing in emerging applications including diagnostics, tissue engineering and drug discovery...
TTP Plc (TTP), a leading independent technology and product development company, today announced that it will be showcasing advances with the development of its Puckdx™ point-of-care diagnostic platform at the 69th AACC Annual Scientific Meeting and Clinical Lab Expo in San Diego, at booth 1658 at the San Diego Centre.
Since the launch of the platform at AACC in 2016, technical developments have made it possible for Puckdx to run quantitative PCR amplification times of 7 mins for 30 cycles. This will enable point-of-care diagnostic providers to rapidly convert their biological assay into a market-ready system capable of producing a result in less than quarter of an hour, for specific assays.
At its core, the Puck dx™ platform uses a novel fluid handling system designed to enable ready translation from bench to disposable. The platform has the flexibility to effectively and efficiently extract DNA and RNA from a range of samples. This, combined with an ultra-fast thermal cycler mod...
A flexible diagnostics platform that provides both rapid time to market and sample to result
TTP plc, Europe's leading technology and product development company, today announces its ongoing partnership with Innova Biosciences (Innova), a specialist provider of bioconjugation products and services, to enable its rapid point-of-care diagnostics development program.
TTP’s Desktop Biology provides fast track development and rapid route to market for companies looking to commercialise their assays. Innova is providing custom magnetic beads and alkaline phosphatase conjugation services, to support the conjugate screening phases of TTP’s assay development.
The original custom project, under which Innova developed magnetic bead conjugation previously not offered either off-the-shelf or as a custom service, involved developing a range of magnetic beads of different diameters conjugated to capture antibodies. Innova produced all conjugates within 1 week of receiving antibody material. Following the success of this initial project the companies are planning to continue to collabor...
Enabling rapid point-of-care diagnostics
The Technology Partnership (TTP) has announced it is supporting an initiative in Cambridgeshire to help teachers with the new skills they need to teach coding to the next generation of learners. The idea is being led by David Anderson, a robotics/software expert and former employee at TTP, who has strong ties to the education sect...
TTP plc funds new robotics lessons to teach coding to teachers and students.
TTP Ventus formed to commercialise micropump technology.
TTP wins IOP Innovation Award for Acoustic Gas Sensor
Translating biological assays into market-ready products that deliver ‘Sample to Answer’ from 15 Minutes
This new service provides an accessible and rapid route to market, offering a seamless approach for companies looking to accelerate the development of their assay to a product for use in diagnostics or research.
Made possible with TTP’s expertise in regulated environments and fast track system development, this advance will enable rapid translation of a customer’s biology to a product on the market.
Key to this service is the ability for TTP’s team to understand the fundamental steps required to convert lab-based biological processes (for example, sample preparation, labelling and assay measurement) to a functional low-cost disposable and small instrument.
The Internet of Things (IoT) is driving investment in new applications to harness opportunities in a new connected world. In his article in IoT Now Steve Baker looks at the danger of focussing to much on the technology and not on how to monetise ...
Do you believe the hype?
A new approach to strain imaging of soft tissue could improve the treatment of cancer and atrial fibrillation. We catch up with UK-based R&D company, The Technology Partnership, once again, to learn about its breakthrough in the field of elastography.
Read the full MedTech Engine article here.
Proudly sponsored by TTP Group, Cambridge Science Festival launches its first Festival film with Professor Lord Martin Rees speaking about our future as a species and artificial intelligence (A...
The ‘Mirage’ display technology recently developed by The Technology Partnership plc (TTP) is to feature as an art installation during the e-Luminate Cambridge Festival this month.
TTP’s Mirage display technology has been turned into a work of Art and will be displayed at the Judge Business School during the 2016 e-Luminate Cambridge Festival. Created by Zero Kb and Visual Poke, the sculptural artwork exploits the unique ability of a Mirage display to appear transparent while able to display a static or video image.
The sculptural artwork comprises 23 small scale Mirage display panels suspended as rotating pieces of glass forming the multiple facets of the sculpture. Adding to the visual impression, each Mirage display will show specially created images.
Mirage Display Technology
TTP’s Mirage technology enables transparent windows or screens to be simultaneously used as a display, transforming internal and external transparent structu...
The Art of Technology
5 minutes with Paul Galluzzo, chief researcher at leading UK R&D company The Technology Partnersh...
Developing revolutionary coating technology
As manufacturers strive to update their businesses for Industry 4.0 and meet customer demands for mass customisation of products, they face the complex task of converting large scale, often manual, production processes into automated digital systems. Today Covestro, a leading player in industrial coatings and adhesive raw materials, and TTP, a technology company with expertise in digital printing, announce a development milestone in digital coating and adhesive technology that has the potential to enable this transition – the successful digital printing of polyurethane adhesives.
The partnership of TTP’s new and revolutionary technology for the rapid digital application of coatings and adhesives, with Covestro’s tailored polyurethane raw materials has demonstrated a new opportunity for digital printing in next generation manufacturing. “We recently successfully tested adhesives formulated with Covest...
The Technology Partnership plc (TTP) is pleased to announce that its novel silent pump technology, Disc Pump, will play a key role in Owlstone’s lung cancer screening system due to enter Phase 2 clinical trials in November. As part of the LuCID (Lung Cancer Indicator Detection) programme, it is hoped the Owlstone technology will lead to a cheaper, smaller and noninvasive method of diagnosing early‐stage lung cancer, and potentially save over 10,000 lives by 20...
“Internet of Things” (IoT) innovators Mayflower and its development partner The Technology Partnership plc (TTP) are pleased to announce that they have been shortlisted for this year’s 2015 IET Innovation Awards. Mayflower and development partner TTP, were shortlisted for the highly successful commercial UK deployment of a ZigBee wireless mesh network‐based street light central management system (CM...
Mayflower and TTP selected as finalists for the Power/Energy category of the 2015 IET Innovation Awards
Edwin Stone shares further insight into how the biology has continued to press onward, whilst the gap between R&D and commercialization remains substantial.
Edwin Stone, TTP, looks at how autologous cell therapy could become a viable option for patients worldwide.
Success and leadership succession were the two themes at the TTP Group 2015 Annual General Meeting (AGM) of shareholders.&nb...
TTP Group reports record results and leadership succession at 2015 Annual General Meeting of shareholders
Bridgestone World Solar Challenge
Exciting new collaboration for Cambridge
“Internet of Things” (IoT) innovators Mayflower and The Technology Partnership (TTP) have continued their winning streak with a second award for best application of I...
TTP applies eddy current principle to high temperature measuring applications.
Companies that embrace the IoS and not the IoT will be the winners in the new connected world.
TTP's Steve Taylor explains why when you cut through the hype around the Internet of Things (IoT), it’s the Internet of Sensors (IoS) and resulting data that matters most.
“The IoT is, to a large extent, a solution looking for a problem, rather than the other way round,” says Steve Taylor, a senior consultant at TTP. “There’s simply no point in objects talking to each other just for the sake of it and the IoT only provides the communications backbone. An Internet of Sensors looks more like the roots of a tree, with sensors of all types at the extremities, capturing and feeding data upwards to the main trunk – the Internet.”
Connecting things over the internet is certainly not new. TTP has been working on machine to machine (M2M) and even organism to machine applications for over 20 years, from sensors to monitor cow herds to sensors in orthopaedic joints and F1 engines. “The IoT hype...
not the Internet of Things.
See our article in t...
TTP recently completed the installation of a new custom Bio-Laboratory. This lab has been designed as a dedicated facility for client projects and TTP internal R&D that requires detailed biological testing and development. Activity already underway in the new lab includes, single cell analytics, cell culturing, digital biology, bio-printing, and bio-chemical work flow automati...
TTP have also made a video about this technology; click here to view.
The Technology Partnership (TTP) has developed an innovative approach to small cells for use on lamp posts that dramatically simplifies the delivery of urban LTE.
With demand for cellular data continuing to rise and outdoor small cells seen as an essential element in the long-term delivery of high-capacity urban networks, TTP has come up with a new small cell designed specifically for deployment on lamp posts.
The use of lamp posts enables the acquisition of many thousands of suitable sites through negotiation with a single city authority. TTP’s new eNodeB is simply fitted into a lamp post’s standard photocell socket, providing the quickest possible installation without any modification to the lighting column or its power supply. And the compact design meets de minimis planning requirements, to simplify planning consents.
TTP’s prototype eNodeB is based on the Freescale BSC9131 QorIQ Qonverge processor and ...
A new digital inkjet technology from a UK-based research and development company promises to cut the cost of customising vehicles, white goods and architectural surfaces, while also saving energy.
To read the full article as featured on The Engineer website click here.
TTP and Mayflower win 'Best Application of The Internet of Things'
Michael Barkway from TTP looks at the current state of play for the IoT without the hype and takes a look into the future.
The term Internet of Things, or IoT, encompasses everything from existing developments in machine-to-machine communications to the newest wearable devices. The vision of the IoT world is that every Thing is connected and discoverable from its own IP address, sharing information freely.
But will the future really be like this? There are good reasons to think that it won’t. This article analyses the nature of the IoT and sets out some of the challenges and opportunities for the next phase of its deployment.
The web today is mostly horizontal – pages of open information, with revenues derived directly through purchasing or indirectly via advertising. The cost model in the Internet today is many-to-one – many consumers to one web server. This has driven revolutionary change in social media, search, file sharing, media distribution and more, enabled by the low co...
TTP, a leading UK technology and product development company, has recently developed an innovative new approach to the intracellular delivery of macromolecules and nano-particles into cells at high speed and high volume. This new technique could have major implications for a range of cellular applications including the transfection of cells with DNA material. TTP has already successfully demonstrated the transport of antibodies into cells and is now beginning to explore other biomolecules and the full capabilities of this exciting technology. This technology relies on a physical effect alone and does not require chemical, electrical poration or biological vectors to enable transport into the cell.
It has been known for some time that relaxation of cell membranes as a result of deformation leads to transient poration to allow molecules or other particles to enter the cell. However, existing approaches to harness this effect typically rely on the use of microfluidics and require pu...
Delivery of macromolecules and nano-particles into cells at high speed and high volume
TTP and Mayflower are pleased to announce that they have completed development of the latest wireless smart lighting control system. An example of the Internet of Things (IoT) in action, this latest design offers over a 50% reduction in power consumption compared to existing smart lighting systems along with enhanced reliability, improved radio range and class leading metering accuracy. The new MK3 design is now available and shipping in volume, with the Zigbee based solution already qualified for sale in North America and beyond this product range dramatically increases Mayflower’s offering.
Smart lighting control is an example of how the Internet of Things can generate real financial savings by embedding intelligence and connectivity into everyday objects. TTP is working on applications from controlling and optimising home energy systems to sensors embedded in smart orthopaedic implants for remote monitoring. With predictions that the IoT will connect up to 50 billion devices b...
Wireless smart lighting control.
The Atlas io™ system enables healthcare professionals to ‘test and treat’ within 30 minutes in their own offices and clinics.
TTP is delighted to announce that it has completed development of the Atlas io™ Reader instrument for Atlas Genetics. The Atlas io™ system is set to revolutionise the diagnosis of infectious diseases by bringing down the time required to take a patient sample and make a diagnosis to less than thirty minutes. This compares with the typical three to ten day turnaround traditionally required to achieve the same diagnosis through a central lab.
The Atlas io™ Reader operates with a test-specific disposable reagent cartridge and fully automates a three-stage process of DNA extraction and purification, DNA amplification, and electrochemical detection of the target infection. The operator simply adds the patient's sample to the cartridge, inserts it into the Reader, and follows on-screen prompts to make the diagnosis.
Achieving this level of simplicity for users ...
TTP and Atlas Genetics development partnership creates ultra-rapid point-of-care instrument for the diagnosis of infectious disease.
TTP, a leading UK-based technology and product development company, has come up with an innovative approach to gas sensing that radically cuts cost, size and power consumption. The new ultrasonic sensor uses patent-pending TTP technology to precisely measure the speed of sound in a gas to determine its composition and can also be connected wirelessly to the Internet for remote monitoring and data collection.
Drawing on TTP’s expertise in nonlinear acoustics and piezoelectric technology, the new SonicSense devices will cost between £3 and £6 each in volume production. TTP is investigating a wide range of industrial and medical applications, from gas safety and process control to respiratory monitoring and anaesthesia. Once the speed of sound through the gas is measured, thermal compensation is applied before the composition of a binary gas mixture is calculated. Additional bulk gas properties such as density can also be determined using the same sensor architecture to enable more co...
New low-cost gas sensor technology from TTP uses speed of sound
TTP’s SonicSense delivers accurate gas sensing at a fraction of the cost of existing methods
Leading Cambridge-based technology innovation company TTP has been awarded a research project by UK radio regulator Ofcom to assess the potential for future improvements in the performance of radio receivers, in particular for TV. The project builds on a previous research programme conducted by TTP for Ofcom in 2009.
As demands on spectrum increase, regulators are looking to enable services such as mobile broadband and White Space to operate alongside broadcast TV. Dr Antony Rix from TTP’s Wireless group commented that, “if TV spectrum in 700MHz is to be released for LTE or other uses, it is critical that TV receivers operating close to these frequencies continue to be able to operate with a very high quality of service.”
TTP’s research will assess the potential for TV receiver performance, specifically adjacent channel selectivity, to be increased. Lewis Davies, who is leading the project at TTP, highlights that, “although the performance of best-in-class silicon tuners now br...
TTP works with Ofcom to assess future development of radio technology
Study to look at how mobile broadband and White Space will operate alongside broadcast TV
Amaru has been working with TTP, a technology and product development company, based in Melbourn, near Royston in Hertfordshire. He was tasked to investigate the possibility of entering a new market area for the company by developing new anti-reflection coating technology. His success in the project has lead to him being nominated as a finalist in the annual ‘The Year in Industry’ awards in which the top category recognises students who have made the most significant contribution to the businesses with which they have been working. The prestigious awards take place at the Royal Academy of Engineering in London on Thursday 19th September.
Amaru is enthusiastic about the year he has spent working in industry before going on to s...
Student Amaru in finals for National Business Award
9 September 2013: Engineers at The Technology Partnership (TTP) have discovered a way to break through the Faraday Cage that prevents the entry or escape of an electromagnetic field through a metallic enclosure. While the Faraday Cage effect does have useful applications from preventing leakage from microwave ovens to lightning strike protection and screening data cables, TTP’s new patent-pending Fluxor technology will have major benefits for power and data transfer through metal shielding. TTP is already using the technology for monitoring fluid levels in steel pipes, taking readings from medical implants and measuring data from inside high-performance F1 engines.
TTP’s Fluxor method creates a ‘window’ for electromagnetic transmission of power and data by applying a strong DC magnetic field, which lines up the magnetic dipoles in the material to ‘saturate’ a small area of the metal screen. This reduces the permeability and increases penetration to make it possible to transfer elec...
TTP beats the Faraday Cage with Fluxor
TTP has today unveiled its ground breaking Vista 3D, which is the first print head technology that can print with more than one material. Unlike existing 3D printing solutions, the same Vista 3D print heads can dispense or print ceramics, and even biological cells, as well as the traditional metals and plastics, opening up the possibility of printing products as diverse as toys, medical devices, aircraft parts and even diagnostic test strips at the touch of a button.
This breakthrough in technology will potentially change the face of manufacturing, as we know it. It will give organisations the ability to print off stock and supplies of complex products that comprise of several materials as and when they need, making the process of ordering goods from the Far East or other manufacturing facilities a thing of the past.
By discovering a breakthrough method in droplet ejection, TTP’s Vista 3D can print large (50 µm+) particles and more viscous and volatile fluids. The open printhe...
Chemical, ceramic and even biological 3D printing is now a reality as TTP unveils new multi-material breakthrough
New Vista 3D is the first printer technology available with mu...
Melbourn Science Park
SG8 6EE UK
Tel: +44 1763 262626
Fax: +44 1763 261582
Registered number: 3304950
Registered office: as shown above
Country of registration: England & Wales
VAT number: 636 9859 76
The Technology Partnership plc is a TTP Group plc company.
© 2018 The Technology Partnership. All rights reserved.